FDA encourages leveraging Sentinel capabilities as a national resource for broader public health and safety evidence generation

FDA Commissioner Dr. Robert Califf writes about the value of IMEDS in supporting FDA’s mission in post-market product safety evidence generation

See full post here: Introducing IMEDS, a Public-Private Resource for Evidence Generation